Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Headline
Life expectancy in the U.S. reached an all-time high of 79 years in 2024, according to a report by the Centers for Disease Control and Prevention. The average…
Headline
Ji Im, system senior director of community and population health at CommonSpirit Health, explores why seamless navigation, community partnerships and…
Blog
As hospitals and health systems look for sustainable and scalable solutions to help address rising behavioral health needs across the country, digital tools…
Headline
The Centers for Medicare & Medicaid Services Dec. 15 published the Measures Under Consideration List for 2025. These are measures that CMS is considering…
Blog
The holiday season is often depicted as a time of joy and celebration, but for health care professionals it can also be a busy and emotionally demanding time…
Headline
The Centers for Medicare & Medicaid Services Dec. 11 announced the launch of the Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based…